| Application no. and date | 12733784.8 (espacenet) (Federated) (European Patent Register), 20120713 | | Patent/reg. no. and date | DK/EP 2731947, 20190116 | | Publication date | 20140521 | | Priority no. and date | EP 11174266, 20110715, EP 12170055, 20120530 | | EP pub. no. and date |
EP 2731947 20140521 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 162278 | | Inventor | KLEIN, Thomas, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim Am Rhein, DE,
PFRENGLE, Waldemar, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim Am Rhein, DE,
FRANK, Markus, Boehringer Ingelheim GmbH
Corporate Patents
Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/155 (2006.01) , C07D 473/06 (2006.01) | | Title | SUBSTITUERET DIMERISK QUINAZOLIN-DERIVAT, FREMSTILLING OG ANDVENDELSE DERAF I FARMACEUTISKE SAMMENSÆTNINGER TIL BEHANDLING AF TYPE I- OG TYPE II-DIABETES | | Int. application no. | EP2012063852 | | Int. publication no. | WO2013010964 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
